SPOTLIGHT -
We're trying to make our stress tests more realistic.
Long-Term Data of Ocrelizumab Highlights Specific Patient Population at Risk for Severe Infection
Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates
CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer Disease
Episode 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS
MS Misdiagnosis Is Still a Problem, But Promising Biomarkers May Be Part of the Solution
Ublituximab Outperforms Teriflunomide in Improving Fatigue in Multiple Sclerosis
